MLNM Forum Topics
- All Comments on MLNM
- General Discussion on MLNM
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? [view article]
- Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom [view article]
- Today's 52-Week High List: Energy Dominates [view article]
- General Electric's Healthcare Disappointment [view article]
- Millennium Has Nothing to Fear from a Takeda Takeover [view article]
- Wall Street Breakfast: Must-Know News [view article]
- Cancer Stocks Hammered Once Again [view article]
- Russell 1,000's Best, Worst Performers Since the 10/9 Top [view article]
- Cancer Stocks Slide Again [view article]
- Cancer Stocks Plunge Following ASCO Meeting [view article]
- Cancer Stocks Soar With Annual ASCO Meeting [view article]
loading ...Recent MLNM Articles
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
- Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom
- Today's 52-Week High List: Energy Dominates
- General Electric's Healthcare Disappointment
- Last Week's Winners and Losers
- Millennium Has Nothing to Fear from a Takeda Takeover
- Wall Street Breakfast: Must-Know News
- Earnings Preview: Millennium Pharmaceuticals
- Strongest Upward Revisions Heading Into Earnings
- Russell 1,000's Best, Worst Performers Since the 10/9 Top
- Full List of Articles »
Finance
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF? [view article]
I agree that there will be continued play in the sector given the desperation of the majors to develop their own drugs internally to offset the massive patent expirations occurring over the next few years.Interestingly, there's a pretty strong seasonality to the biotech sector and we're still in the trough. Generally such trends are spotted quickly and evaporate due to efficient markets within a couple years, but this one's still in place it seems (I had used BBH as my proxy due to longer tenure, but trade with XBI due to better representation of the sector and less reliance on AMGN, DNA).
The sector outperforms big time in the late fall/winter on a pretty routine basis:
everydayfinance.blogsp...
Reply
Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom [view article]
Kinda funny to me that MA would be considered a Technology Stock.?? ReplyRussell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom [view article]
MA will hit 300 by the end of the week easily ReplyToday's 52-Week High List: Energy Dominates [view article]
nearly 80% of world oil reserves are controlled by state-owned firms ReplyGeneral Discussion on MLNM
With all the talk about the buy out of Millennium.....What are your thoughts? Would it be a good idea to sell out or maybe buy up some more stock. I have held MLNM for the last 5 years and I am pleased with it's performance. ReplyToday's 52-Week High List: Energy Dominates [view article]
FSLR is not an industrial! ReplyToday's 52-Week High List: Energy Dominates [view article]
should match this with list of 52 week lows ReplyThe Wind
Today's 52-Week High List: Energy Dominates [view article]
I'd like to see another article on upcoming ex-dates for high yield CEFs. ReplyToday's 52-Week High List: Energy Dominates [view article]
Thank you. Good job. Replyor
General Electric's Healthcare Disappointment [view article]
Efforts by payers to lower healthcare expenditures point to the need for medical products companies to re-orient towards cost-effectiveness. This is not necessarily bearish for med-tech companies ReplyGeneral Electric's Healthcare Disappointment [view article]
Insurance is nothing more than privatized socialism. The patient has no incentive to be efficient because he "paid his premiums," and the medical providers desire to extract as much money as possible from the pools of premium monies is hardly restrained by a bureaucrat far removed from the patient/doctor exchange.Because of the patients lack of incentive and the medical providers unrestrained incentive, health care costs have escalated to bubble like proportions. So much so that the word doctor has become synonymous with millionaire.
Both privatized insurance and socialized insurance, are doomed to collapse because both circumvent the consumer/producer negotiations.
Are we approaching that point? Is the bubble bursting in the health care industry? Politicians sure have been talking up solutions to rising health care costs over the last number of election cycles. The problem is that their solutions are what created the bubble in the first place (ie socialized medicine in the form of medicare and medicaid.) Now they want to expand the program to cover everyone beyond just seniors. If the politicians get their way, there may be another leg up for the health care providers with the expanded pool of new monies brought on by coercing all to participate in health care socialism.
Reply
Millennium Has Nothing to Fear from a Takeda Takeover [view article]
Totally agree with you that Takeda will leave current management alone in managing the company. Japanese pharmas are not very good with finding new drugs and they are definately buying this biotech to enhance its ability. To allow Millennium to perform to its full potential, I am sure Takeda understands less invlovement is actaully the better way. ReplyMillennium Has Nothing to Fear from a Takeda Takeover [view article]
Bad for stockholders. Cash deal creates tax impact while a stock swap would give a choice. Also, I think the pipeline is worth much more. Velcade alone might well be one of the greatest blockbusters of history. I think this is deal suspect. ReplyJacome
Millennium Has Nothing to Fear from a Takeda Takeover [view article]
MGI Pharma, then PHRM, then MLNM -- BMRN is next, we think. Also hearing BIIB is still trying to get something done by year end.Reply
McCorkle
Wall Street Breakfast: Must-Know News [view article]
Re: GregoryYConsidering that Soros makes more money in the markets in a week than Greenspan has in a lifetime, I think I know who opinion I value Reply